North America Pruritus Therapeutics Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The North America Pruritus Therapeutics Market would witness market growth of 3.7% CAGR during the forecast period (2023-2030).

Therapeutics used to treat pruritus are referred to as pruritus therapeutics. The itching of the skin caused by various ailments, including dry skin, allergies, and other ailments, is known as pruritus. When pruritus endures longer, it usually indicates a more serious underlying cause. Eczema, or atopic dermatitis (AD), can be brought on by an increased inflammatory reaction to various potential irritants, including dust, environmental contaminants, animals, and specific foods. Typical contact dermatitis-inducing products include watches, soaps, clothes, and jewelry, potentially irritating substances.

The pruritus results from stimulation from dermal tissue-free nerve endings that are transferred through the spinal cords, C-fibers, and the spinothalamic tract. Itching or pruritus is the result of this process. Since this condition is a sign of neurologic disorders, chronic renal failure, cholestasis, systemic infections, cancers, endocrine diseases, exposure to certain medicines, and hepatitis, it is also a symptom of those disorders. A thorough evaluation combining a clinical examination and laboratory tests is necessary to determine the actual cause of pruritus. These tests may be dermatologic, systemic, neurogenic, or psychological. The market includes selling dermatological products intended to treat pruritus. Corticosteroids have been used externally by medical experts to treat pruritus. The first line of treatment for skin conditions such as pruritus, allergic contact dermatitis, and AD has been corticosteroids.

In a study by the National Library of Medicine on the prevalence of atopic dermatitis in Canada, 76 patients with AD in the state of Ontario participated in a survey to learn more about the disease's severity, visits to the doctor, use of over-the-counter medications, household costs, and absenteeism related to the condition. Furthermore, 38.0% of the adult population in the U.S., or 96 million people, had prediabetes. The high prevalence of diabetes in the region, which may also increase the risk of pruritus, is expected to provide potential opportunities for the market.

The US market dominated the North America Pruritus Therapeutics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.0 billion by 2030. The Canada market is poised to grow at a CAGR of 6% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 5.1% during (2023 - 2030).

Based on Disease Type, the market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria and Others. Based on Product, the market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bristol Myers Squibb Company, Novartis AG, Pfizer, Inc., Sanofi S.A., Astellas Pharma, Inc., Cara Therapeutics, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceuticals Industries Ltd., Amgen, Inc., and AbbVie, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Others

By Product

Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Others

By Distribution Channel

Drug Stores & Retail Pharmacies
Hospital Pharmacies
Online Providers

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Bristol Myers Squibb Company
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Astellas Pharma, Inc.
Cara Therapeutics, Inc.
GlaxoSmithKline PLC (GSK)
Teva Pharmaceuticals Industries Ltd.
Amgen, Inc.
AbbVie, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Pruritus Therapeutics Market, by Disease Type
- 1.4.2 North America Pruritus Therapeutics Market, by Product
- 1.4.3 North America Pruritus Therapeutics Market, by Distribution Channel
- 1.4.4 North America Pruritus Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Force Analysis

Chapter 4. North America Pruritus Therapeutics Market by Disease Type

4.1 North America Atopic Dermatitis Market by Country
4.2 North America Allergic Contact Dermatitis Market by Country
4.3 North America Urticaria Market by Country
4.4 North America Others Market by Country

Chapter 5. North America Pruritus Therapeutics Market by Product

5.1 North America Corticosteroids Market by Country
5.2 North America Antihistamines Market by Country
5.3 North America Local Anesthetics Market by Country
5.4 North America Counterirritants Market by Country
5.5 North America Immunosuppressant Market by Country
5.6 North America Calcineurin Inhibitors Market by Country
5.7 North America Others Market by Country

Chapter 6. North America Pruritus Therapeutics Market by Distribution Channel

6.1 North America Drug Stores & Retail Pharmacies Market by Country
6.2 North America Hospital Pharmacies Market by Country
6.3 North America Online Providers Market by Country

Chapter 7. North America Pruritus Therapeutics Market by Country

7.1 US Pruritus Therapeutics Market
- 7.1.1 US Pruritus Therapeutics Market by Disease Type
- 7.1.2 US Pruritus Therapeutics Market by Product
- 7.1.3 US Pruritus Therapeutics Market by Distribution Channel
7.2 Canada Pruritus Therapeutics Market
- 7.2.1 Canada Pruritus Therapeutics Market by Disease Type
- 7.2.2 Canada Pruritus Therapeutics Market by Product
- 7.2.3 Canada Pruritus Therapeutics Market by Distribution Channel
7.3 Mexico Pruritus Therapeutics Market
- 7.3.1 Mexico Pruritus Therapeutics Market by Disease Type
- 7.3.2 Mexico Pruritus Therapeutics Market by Product
- 7.3.3 Mexico Pruritus Therapeutics Market by Distribution Channel
7.4 Rest of North America Pruritus Therapeutics Market
- 7.4.1 Rest of North America Pruritus Therapeutics Market by Disease Type
- 7.4.2 Rest of North America Pruritus Therapeutics Market by Product
- 7.4.3 Rest of North America Pruritus Therapeutics Market by Distribution Channel

Chapter 8. Company Profiles

8.1 Bristol Myers Squibb Company
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
8.2 Novartis AG
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
8.3 Pfizer, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional & Segmental Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Approvals:
- 8.3.6 SWOT Analysis
8.4 Sanofi S.A.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 SWOT Analysis
8.5 Astellas Pharma, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 SWOT Analysis
8.6 Cara Therapeutics, Inc.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Research & Development Expenses
- 8.6.4 Recent strategies and developments:
  - 8.6.4.1 Partnerships, Collaborations, and Agreements:
- 8.6.5 SWOT Analysis
8.7 GlaxoSmithKline PLC (GSK)
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 Teva Pharmaceutical Industries Ltd.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 SWOT Analysis
8.9 Amgen, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Regional Analysis
- 8.9.4 Research & Development Expenses
- 8.9.5 SWOT Analysis
8.10. AbbVie, Inc.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 Recent strategies and developments:
  - 8.10.5.1 Approvals & Trials:
- 8.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 North America Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 3 North America Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 4 North America Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 5 North America Atopic Dermatitis Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Atopic Dermatitis Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Allergic Contact Dermatitis Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Allergic Contact Dermatitis Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Urticaria Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Urticaria Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 14 North America Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 15 North America Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Corticosteroids Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Antihistamines Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Antihistamines Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Local Anesthetics Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Local Anesthetics Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Counterirritants Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Counterirritants Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Immunosuppressant Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Immunosuppressant Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Calcineurin Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Calcineurin Inhibitors Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 30 North America Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 31 North America Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Pruritus Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Pruritus Therapeutics Market by Country, 2023 - 2030, USD Million
TABLE 39 US Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 40 US Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 41 US Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 42 US Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 43 US Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 44 US Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 45 US Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 US Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Canada Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 48 Canada Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 49 Canada Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 50 Canada Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 51 Canada Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 52 Canada Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 53 Canada Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 Canada Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 Mexico Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 56 Mexico Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 57 Mexico Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 58 Mexico Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 59 Mexico Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 60 Mexico Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 61 Mexico Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 Mexico Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 Rest of North America Pruritus Therapeutics Market, 2019 - 2022, USD Million
TABLE 64 Rest of North America Pruritus Therapeutics Market, 2023 - 2030, USD Million
TABLE 65 Rest of North America Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
TABLE 66 Rest of North America Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
TABLE 67 Rest of North America Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
TABLE 68 Rest of North America Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
TABLE 69 Rest of North America Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 Rest of North America Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 71 Key Information - Bristol Myers Squibb Company
TABLE 72 Key Information - Novartis AG
TABLE 73 Key Information - Pfizer, Inc.
TABLE 74 Key Information - Sanofi S.A.
TABLE 75 key information - Astellas Pharma, Inc.
TABLE 76 Key Information - Cara Therapeutics, Inc.
TABLE 77 Key Information - GlaxoSmithKline PLC
TABLE 78 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 79 Key Information - Amgen, Inc.
TABLE 80 Key information - AbbVie, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 North America Pruritus Therapeutics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Pruritus Therapeutics Market
FIG 4 Porter's Five Force Analysis: Pruritus Therapeutics Market
FIG 5 North America Pruritus Therapeutics Market share by Disease Type, 2022
FIG 6 North America Pruritus Therapeutics Market share by Disease Type, 2030
FIG 7 North America Pruritus Therapeutics Market by Disease Type, 2019 - 2030, USD Million
FIG 8 North America Pruritus Therapeutics Market share by Product, 2022
FIG 9 North America Pruritus Therapeutics Market share by Product, 2030
FIG 10 North America Pruritus Therapeutics Market by Product, 2019 - 2030, USD Million
FIG 11 North America Pruritus Therapeutics Market share by Distribution Channel, 2022
FIG 12 North America Pruritus Therapeutics Market share by Distribution Channel, 2030
FIG 13 North America Pruritus Therapeutics Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 North America Pruritus Therapeutics Market share by Country, 2022
FIG 15 North America Pruritus Therapeutics Market share by Country, 2030
FIG 16 North America Pruritus Therapeutics Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Bristol Myers Squibb Company
FIG 18 SWOT Analysis: Novartis AG
FIG 19 SWOT Analysis: Pfizer, Inc.
FIG 20 Swot Analysis: Sanofi S.A.
FIG 21 SWOT Analysis: Astellas Pharma, Inc.
FIG 22 SWOT Analysis: CARA THERAPEUTICS, INC.
FIG 23 SWOT Analysis: GlaxoSmithKline PLC
FIG 24 Swot Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 25 Swot Analysis: Amgen, Inc.
FIG 26 Swot Analysis: AbbVie, Inc.

North America Pruritus Therapeutics Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents